23andMe to follow FDA order to halt test sales



Estimated read time: 1-2 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

MOUNTAIN VIEW, Calif. (AP) - Genetic testing company 23andMe says it is complying with a Food and Drug Administration directive to stop selling health-related genetic tests during a regulatory review.

The Mountain View, Calif., company said late Thursday that it will continue to provide ancestry-related information to customers and raw genetic data without interpretation. Customers who bought kits since the FDA order came out last month will be eligible for refunds.

23andMe Inc. sells the health-related tests as a way to help users predict their risk of developing various diseases. But last month, the FDA ordered the company to stop sales. It says 23andMe has failed to show that the technology is supported by science.

23andMe sells its tests online. Customers receive a small tube in the mail, which they return to the company with a saliva sample for DNA analysis.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

SIGN UP FOR THE KSL.COM NEWSLETTER

Catch up on the top news and features from KSL.com, sent weekly.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

KSL Weather Forecast